Daily Monitoring of Exhaled Nitric Oxide in Asthmatic Patients
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01113853 |
Recruitment Status
:
Completed
First Posted
: April 30, 2010
Last Update Posted
: May 3, 2010
|
Sponsor:
Universita di Verona
Collaborator:
Azienda Ospedaliera Universitaria Policlinico
Information provided by:
Universita di Verona
Tracking Information | ||||
---|---|---|---|---|
First Submitted Date | April 28, 2010 | |||
First Posted Date | April 30, 2010 | |||
Last Update Posted Date | May 3, 2010 | |||
Study Start Date | January 2007 | |||
Primary Completion Date | Not Provided | |||
Current Primary Outcome Measures | Not Provided | |||
Original Primary Outcome Measures | Not Provided | |||
Change History | Complete list of historical versions of study NCT01113853 on ClinicalTrials.gov Archive Site | |||
Current Secondary Outcome Measures | Not Provided | |||
Original Secondary Outcome Measures | Not Provided | |||
Current Other Outcome Measures | Not Provided | |||
Original Other Outcome Measures | Not Provided | |||
Descriptive Information | ||||
Brief Title | Daily Monitoring of Exhaled Nitric Oxide in Asthmatic Patients | |||
Official Title | Daily Monitoring of Exhaled Nitric Oxide in Asthmatic Patients Stopping Anti-inflammatory Treatment | |||
Brief Summary | Previous studies have demonstrated that exhaled nitric oxide can be useful to monitor the efficacy of anti-inflammatory treatment as well as to predict a risk of asthma relapse in asthmatic patients. The aim of the present study is to evaluate the time course of exhaled nitric oxide in mild asthmatic patients, stopping regular treatment with inhaled corticosteroids, if it is possible, in relationship with symptoms and lung function. |
|||
Detailed Description | All patients were evaluated with pulmonary lung function, exhaled nitric oxide and peak expiratory flow (PEF) and fill in a personal diary for the first two weeks when patients are in treatment; the same evaluation will be made for other four weeks without treatment. | |||
Study Type | Observational | |||
Study Design | Observational Model: Case-Only Time Perspective: Cross-Sectional |
|||
Target Follow-Up Duration | Not Provided | |||
Biospecimen | Not Provided | |||
Sampling Method | Probability Sample | |||
Study Population | children with asthma visited in the outpatients clinic at University of Verona were invited to participate to the study | |||
Condition | Asthma | |||
Intervention | Not Provided | |||
Study Groups/Cohorts | Not Provided | |||
Publications * | Not Provided | |||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
||||
Recruitment Information | ||||
Recruitment Status | Completed | |||
Actual Enrollment |
40 | |||
Original Actual Enrollment | Same as current | |||
Actual Study Completion Date | January 2010 | |||
Primary Completion Date | Not Provided | |||
Eligibility Criteria | Inclusion Criteria:
Exclusion Criteria:
|
|||
Sex/Gender |
|
|||
Ages | 5 Years and older (Child, Adult, Senior) | |||
Accepts Healthy Volunteers | No | |||
Contacts | Contact information is only displayed when the study is recruiting subjects | |||
Listed Location Countries | Italy | |||
Removed Location Countries | ||||
Administrative Information | ||||
NCT Number | NCT01113853 | |||
Other Study ID Numbers | AOV 1360 | |||
Has Data Monitoring Committee | No | |||
U.S. FDA-regulated Product | Not Provided | |||
IPD Sharing Statement | Not Provided | |||
Responsible Party | attilio L Boner, Università di Verona | |||
Study Sponsor | Universita di Verona | |||
Collaborators | Azienda Ospedaliera Universitaria Policlinico | |||
Investigators |
|
|||
PRS Account | Universita di Verona | |||
Verification Date | January 2007 |